Fatty liver screening

Fatty Liver Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Fatty Liver from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Fatty liver screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Fatty liver screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Fatty liver screening
CDC on Fatty liver screening
Fatty liver screening in the news
Blogs on Fatty liver screening
Directions to Hospitals Treating Fatty liver
Risk calculators and risk factors for Fatty liver screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Screening

Per the American Gastroenterological Association (AGA) in 2021, screening should be:

• Diabetes mellitus Type 2
• 2 or more metabolic risk factors (entral obesity, high triglycerides, low HDL cholesterol, hypertension, prediabetes, or insulin resistance)
• Excessive alcohol intake
• Steatosis on any imaging modality or elevated aminotransferases

Per the American Association for the Study of Liver Diseases (AASLD) in 2023:

• "All patients with hepatic steatosis or clinically suspected NAFLD based on the presence of obesity and metabolic risk factors should undergo primary risk assessment with FIB-4."